Shilstine 50 mg Injection

Product Description

Shilstine 50 mg Injection serves as a vital therapeutic agent designed to mitigate the harmful effects of certain chemotherapy drugs, particularly methotrexate, and effectively addresses cases of overdose from anticancer treatments. This injectable formulation is particularly beneficial for patients suffering from megaloblastic anemia caused by folic acid deficiency when oral medications are not feasible. Additionally, Shilstine is often administered in conjunction with 5-fluorouracil to enhance treatment outcomes in advanced colorectal cancer. While it plays a crucial role in cancer therapy and supportive care, it is essential for patients to be aware of potential side effects and consult with healthcare professionals before use. Shilstine works by replenishing folate levels in the body, which is critical for DNA synthesis and repair, thereby supporting healthy cell function during rigorous cancer treatments. As a physician-recommended option, this injection underscores the importance of tailored cancer care, ensuring patients receive comprehensive support throughout their treatment journey. Always discuss your medical history and any ongoing medications with your healthcare provider to avoid complications.